Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Frankel

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Hematotherapy|November 22, 1997
A pilot study evaluating interleukin-2-activated hematopoietic stem cell transplantation for hematologic malignanciesK R Meehan, A Badros, S R Frankel, et al.
Cancer Research|April 25, 1992
Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemiaJ R Muindi, S R Frankel, C Huselton, et al.
Seminars in Oncology|December 1, 1993
High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemiaM R Baer, N P Christiansen, S R Frankel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 1992
Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemiaW H Miller, A Kakizuka, S R Frankel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Extended rituximab therapy in Waldenström's macroglobulinemiaS P Treon, C Emmanouilides, E Kimby, et al.
Blood|January 25, 1992
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemiaJ Muindi, S R Frankel, W H Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumorsJ Marshall, H Chen, D Yang, et al.
Cell|September 2, 1991
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PMLA Kakizuka, W H Miller, K Umesono, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2008
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphomaM Crump, B Coiffier, E D Jacobsen, et al.
The Journal of Clinical Investigation|July 6, 2000
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapyT A Fehniger, E M Bluman, M M Porter, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Hematotherapy|November 22, 1997
A pilot study evaluating interleukin-2-activated hematopoietic stem cell transplantation for hematologic malignanciesK R Meehan, A Badros, S R Frankel, et al.
Cancer Research|April 25, 1992
Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemiaJ R Muindi, S R Frankel, C Huselton, et al.
Seminars in Oncology|December 1, 1993
High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemiaM R Baer, N P Christiansen, S R Frankel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 1992
Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemiaW H Miller, A Kakizuka, S R Frankel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Extended rituximab therapy in Waldenström's macroglobulinemiaS P Treon, C Emmanouilides, E Kimby, et al.
Blood|January 25, 1992
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemiaJ Muindi, S R Frankel, W H Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumorsJ Marshall, H Chen, D Yang, et al.
Cell|September 2, 1991
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PMLA Kakizuka, W H Miller, K Umesono, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2008
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphomaM Crump, B Coiffier, E D Jacobsen, et al.
The Journal of Clinical Investigation|July 6, 2000
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapyT A Fehniger, E M Bluman, M M Porter, et al.
Pageof 4